The medical tubing market is projected to reach USD 18.41 billion by 2030 from USD 12.53 billion in 2025, at a CAGR of 8.0% during the forecast period. The market research study includes information on market factors such as the market dynamics, drivers, restraints, challenges, threats, medical tubing market growth, opportunities, market trends, development patterns, financial information, latest technologies, innovations, leading competitors, and regional analysis of the market. The US medical tubing market is experiencing robust growth due to a mix of demographic changes, technological advancements, and a changing healthcare environment. One of the major drivers of this growth is the increasing aging population that results in increasing demand for medical procedures that involve tubing, including catheters, IV lines, and drug delivery systems. This demographic phenomenon is also associated closely with an increased prevalence of chronic illnesses such as diabetes, cardiovascular conditions, and renal disease, which need continuous and sophisticated medical intervention sustained by tubing technologies.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162082103
Progress in tubing manufacturing technologies and tubing material developments has also contributed substantially to market development. Developments in extrusion techniques now enable the production of more flexible, stronger, and application-specific tubing such as braided or multi-lumen types—that are resistant to chemical exposure as well as static interference. The scale of the US healthcare industry and its investability heavily favor the use of cutting-edge medical technologies. In 2023, Freudenberg Medical expanded its medical tubing production in Massachusetts. The company added silicone extrusion capabilities to better serve its Eastern US customers with custom tubing solutions. This expansion helped the company to increase its production capacity. In 2023, Lubrizol Corporation's Life Science Health expanded its medical device design center in Corona, California.
Rubber material to have the largest share in the US medical tubing market during the forecast period.
Rubber has the highest share in the US medical tubing market owing to its higher flexibility, toughness, and biocompatibility. Silicone and thermoplastic elastomers (TPEs), which are medical-grade rubber-based materials, provide excellent chemical, heat, and sterilization resistance, and hence are suitable for medical applications like IV tubing, catheters, and respiratory devices. In contrast to hard plastics or metals, rubber tubing offers good elasticity with simplicity of fluid movement and patient comfort. Moreover, its non-reactive and non-toxic character makes it safe for direct use on body tissues and fluids. Silicone rubber is especially preferred due to its hypoallergenicity and ability to resist exposure to extreme conditions without degrading. The increasing demand for minimally invasive surgeries and advanced drug delivery systems has also fueled the utilization of rubber-based tubing further. Besides, the increased prevalence of chronic diseases, an aging population, and the expansion of healthcare infrastructure globally substantiate the long-term demand for medical rubber tubing. With medical device companies focusing their energy on designing innovative and high-performance tubing solutions, rubber continues to reign supreme in the market with reliability, security, and effectiveness in critical medical applications.
Get a Sample Copy of This Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=162082103
Catheters & cannulas application to have the largest share in the US medical tubing market during the forecast period.
Catheters & cannulas account for the largest share of the US medical tubing market based on their primary uses in the majority of medical interventions, including drug delivery, fluid withdrawal, and minimally invasive procedures. They are predominantly used in hospitals, clinics, and home care facilities for applications like urinary catheterization, intravenous (IV) therapy, dialysis, and cardiovascular interventions. The rising prevalence of chronic illnesses like cardiovascular disease, kidney disease, and diabetes has significantly boosted demand for catheters & cannulas. Furthermore, the advances made in medical science, such as the introduction of antimicrobial and biocompatible materials, have improved the effectiveness and safety of these devices, which has also augmented their applications. Increasing surgical procedures, along with the growing population of elderly patients in need of long-term medical treatment, have also driven market growth. In addition, rising demands for minimally invasive procedures have created new catheter models, including balloon catheters and guidewires, that improve accuracy and patient comfort. Governments and healthcare institutions globally are also investing more in better healthcare infrastructure, thus increasing demand for these life-supporting medical devices. As a result, catheters & cannulas continue to be dominant in the medical tubing industry, with successful patient care and improved medical outcomes.
In addition, in 2024, Spectrum Plastics Group expanded its business by scaling up its manufacturing services by introducing catheter technologies at its Minneapolis, Minnesota facility. The expansion of this facility helped the company to offer medical tubing to the interventional and surgical markets.
In terms of structure, multi-lumen to hold the largest share in the US medical tubing market during forecast period.
Multi-lumen tubing commands the largest share among US medical tubing products due to its structurally advanced design that meets the multi-dimensional demands of modern healthcare. Single-lumen tubing with a single channel contrasts with multi-lumen tubing, which consists of multiple independent lumens within one tube for simultaneous delivery of fluid, gas, or instruments. This design maximizes efficiency by reducing the need for multiple tubes, making processes like catheterization or dialysis easier, and reducing patient discomfort. Its compact, integrated nature is less invasive than alternatives and is therefore ideal for complex applications like minimally invasive surgery. The structural flexibility of multi-lumen tubing also contributes to its dominance. Each lumen can be designed in size and shape to be used for different functions—delivery of drugs, measurement of vital signs, or drainage of fluids—yet all in the same tube. Constructed from elastic, biocompatible materials like silicone or polyurethane, it will not kink or buckle under stress, ensuring functionality. The durability and elasticity are commensurate with the increased demand for sophisticated medical devices with the increase in chronic conditions and surgery procedures. By providing multifunctionality, miniaturization, and high performance in one form, multi-lumen tubing performs better than simpler designs, solidifying its market leadership as an effective, patient-friendly product for a wide range of medical applications.
Speak to Expert: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=162082103
US to be the largest market in North America during the forecast period.
The US has the largest share in North America's medical tubing market due to its developed healthcare infrastructure, high healthcare expenditure, and dominant presence of world-class medical device manufacturers. Being the most populated and economically dominant country in the region, the US has an extensive chain of hospitals, clinics, and research institutions that persistently need high-grade medical devices that contain tubing components. They range from catheters, IV lines, dialysis machines, to drug infusion devices. Healthcare expenditure in the country is among the highest globally, as Medicare and Medicaid are contributing strongly to high spending on technology advancing patient safety and care—hence the additional increased demand for high-tech tubing solutions. The second most important consideration is the emphasis on technological advancement in the US. It has various world's leading medical device manufacturers, such as Freudenberg Medical, W. L. Gore & Associates, Inc., The Lubrizol Corporation, Spectrum Plastics Group, Zeus Company LLC, NewAge Industries, and Nordson Corporation, which pour significant amounts of money into research and development to create leading-edge tubing material and design. These innovations support the growing trend of minimally invasive procedures and allow specialized tubing to be used for complex procedures. US-based firms are also at the forefront of creating biocompatible and regulatory-compliant materials, like Di(2-ethylhexyl) Phthalate {DEHP}-free polyvinyl chloride (PVC) and medical-grade silicone, that meet Food & Drug Administration (FDA) standards and ensure safe and effective use in clinical settings.
This dominance is attributed to well-established flat glass manufacturers such as Behrenberg Glass Co., Guardian Industries, Cardinal Glass Industries, Inc., and Gillinder Brothers, Inc. These companies manufacture various flat glass products that serve a wide range of end-use industries.
The US medical tubing market report comprises key manufacturers such as Saint-Gobain (France), Freudenberg Medical (US), W. L. Gore & Associates, Inc. (US), The Lubrizol Corporation (US), Nordson Corporation (US), Teknor Apex (US), Spectrum Plastics Group (US), Zeus Company LLC (US), NewAge Industries (US), and Tekni-Plex, Inc. (US), among others.
Saint-Gobain (France) is a French multinational corporation dedicated to industrial construction materials and services manufacturing and distribution. The medical tubing business segment operates under its subsidiary Saint-Gobain Performance Plastics which trades as Saint-Gobain Life Sciences. The division of Saint-Gobain Performance Plastics develops numerous high-performance materials and component products including medical tubing products for medical applications in healthcare sectors. It produces medical tubing products from thermoplastics, silicones and ultra-engineered polymers for hospital and pharmaceutical and laboratory sectors. The company operates through four regional business units - Northern Europe; Southern Europe, Middle East & Africa; Americas, and Asia Pacific and a global high performance solutions unit. The high performance solutions business unit of the company provides medical tubing products as part of its offerings. The industrial facilities of the company exist in 75 different nations.
Inquire Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=162082103
The company operates its manufacturing operations in 21 international locations throughout the world. The company operates production spaces that extend across US, France, India, China, Germany and Japan. The company dedicated USD 85.5 million to research in 2023 to create advanced biomedical materials that would pass medical criteria for precision and durability and compatibility. MS Techniques and Transluminal acquired by the company further strengthened its market presence in medical tubing through France-based industrial assets that improved high-precision thermoplastic extrusion capabilities while expanding its catheter solutions with minimal invasion procedures.
Freudenberg Medical (US), a division of Germany-based Freudenberg Group, develops medical components and devices while also designing and manufacturing them. By operating under Freudenberg Group's specialties business area the company delivers catheters, hypotubes and balloons with minimally invasive procedure coating solutions alongside steerable shafts, engineered needles and precision-molded components and medical silicone and plastic tubing. Freudenberg Medical operates 11 manufacturing facilities through corporate branches located across the Americas, Europe and Asia servicing Costa Rica, India, China, Ireland, Singapore, the United States and Germany. During 2023 Freudenberg Medical allocated USD 653.2 million to research and development while maintaining 5.1% of its total sales for innovation-based research. Freudenberg Medical enlarged its production site in Carrick-on-Shannon, Co. Leitrim, Ireland in November 2024 through its 16,500 sq. ft. expansion which raised the total building area to 157,000 sq. ft. This expansion strengthened its ability to create cutting-edge catheters for electrophysiology, structural heart and peripheral vascular therapies. The company achieved growth through its expansion of biopharma products which utilizes silicone extrusion and molding experience to improve its position in the biopharma sector. The growing worldwide need for precise components along with medical devices guided its USD 25 million investment to create a second production center in Costa Rica which increased its manufacturing presence.
The increasing adoption of the real-time tracking technology, due to the surging integration of the internet of things (IoT) in the transportation and logistics sector, is one of the major factors fueling the demand for last mile delivery solutions across the globe.
On the other hand, the delivery-partner-centric real-time tracking technology allows businesses to get a holistic view of the efficiency of logistics.Request to Get the Sample Report: https://www.psmarketresearch.com/market-analysis/last-mile-delivery-market/report-sampleThis, in turn, inspires them to become more customer-centric.
The adoption of this technology has propelled the expansion of the e-commerce industry.
It has become imperative for both logistics service providers and e-commerce players to have a well-developed information technology (IT) infrastructure in place for enabling the efficient tracking of transactions and the movement of shipments at all times.
Besides this, the huge funding being provided to last mile delivery start-ups is also fueling the last mile delivery market advancement.Many venture capitalists and investors are making huge investments in start-ups operating in last mile logistics for expanding their businesses.
For example, Lalamove, which is an on-demand logistics provider based in Hong Kong, raised funding worth $300 million in its series D round in 2019 for expanding its operations across Asia-Pacific (APAC).
